Barbadin
featured

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H525345

CAS#: 356568-70-2

Description: Barbadin is a novel selective β-arrestin/β2-adaptin inhibitor, blocking agonist-promoted endocytosis of the prototypical β2-adrenergic (β2AR), V2-vasopressin (V2R) and angiotensin-II type-1 (AT1R) receptors, showing no affectinng on β-arrestin-independent (transferrin) or AP2-independent (endothelin-A) receptor.


Chemical Structure

img
Barbadin
CAS# 356568-70-2

Theoretical Analysis

Hodoodo Cat#: H525345
Name: Barbadin
CAS#: 356568-70-2
Chemical Formula: C19H15N3OS
Exact Mass: 333.09
Molecular Weight: 333.409
Elemental Analysis: C, 68.45; H, 4.53; N, 12.60; O, 4.80; S, 9.62

Price and Availability

Size Price Availability Quantity
10mg USD 500 2 Weeks
25mg USD 900 2 Weeks
50mg USD 1500 2 Weeks
100mg USD 2500 2 Weeks
Bulk inquiry

Synonym: Barbadin

IUPAC/Chemical Name: 3-Azanyl-5-[4-(phenylmethyl)phenyl]thieno[2,3-d]pyrimidin-4-one

InChi Key: OCBXPCSXEQQADU-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H15N3OS/c20-22-12-21-18-17(19(22)23)16(11-24-18)15-8-6-14(7-9-15)10-13-4-2-1-3-5-13/h1-9,11-12H,10,20H2

SMILES Code: O=C1C(C(C2=CC=C(CC3=CC=CC=C3)C=C2)=CS4)=C4N=CN1N

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target: Barbadin is a β-arrestin/β2-adaptin interaction inhibitor with IC50 values of 19.1 μM for β-arrestin1 and 15.6 μM for β-arrestin2.
In vitro activity: Barbadin selectively inhibited β-Arr/AP2 interaction in AVP-stimulated V2R receptor of triple-negative breast cancer cells (MDA MB-231). Barbadin reduced cell viability to 69.1% and increased the autophagy marker LC3II and its autophagic effect disappeared in cells transiently starved in Earle's balanced salt solution (EBSS). Also, Barbadin mildly enhanced the expression of P62 mRNA and arrested 63.7% of cells in G0/G1 phase. Reference: Med Oncol. 2021 Mar 15;38(4):38. https://link.springer.com/article/10.1007%2Fs12032-021-01484-z
In vivo activity: Barbadin (Bar), a novel β-arrestin/β2-adaptin inhibitor, potentiated long-term effects of lorcaserin (Lor) to reduce appetite and body weight in male mice. Bar co-treatment effectively maintained the sensitivity of the 5-HT2CR in POMCARH neurons, despite prolonged Lor exposure, thereby allowing these neurons to be activated through opening the transient receptor potential cation (TRPC) channels. These results prove the concept that inhibition of 5-HT2CR desensitization can be a valid strategy to improve the long-term weight loss effects of Lor or other 5-HT2CR agonists, and also provide an intellectual framework to develop effective long-term management of weight by targeting 5-HT2CR desensitization. Reference: J Neurosci. 2021 Jun 30;41(26):5734-5746. https://www.jneurosci.org/content/41/26/5734.long

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 50.0 149.97

Preparing Stock Solutions

The following data is based on the product molecular weight 333.41 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Donia T, Abouda M, Kelany M, Hessien M. β-Arrestin inhibition induces autophagy, apoptosis, G0/G1 cell cycle arrest in agonist-activated V2R receptor in breast cancer cells. Med Oncol. 2021 Mar 15;38(4):38. doi: 10.1007/s12032-021-01484-z. PMID: 33721131. 2. He Y, Liu H, Yin N, Yang Y, Wang C, Yu M, Liu H, Liang C, Wang J, Tu L, Zhang N, Wang L, He Y, Fukuda M, Wu Q, Sun Z, Tong Q, Xu Y. Barbadin Potentiates Long-Term Effects of Lorcaserin on POMC Neurons and Weight Loss. J Neurosci. 2021 Jun 30;41(26):5734-5746. doi: 10.1523/JNEUROSCI.3210-20.2021. Epub 2021 May 24. PMID: 34031163; PMCID: PMC8244968.
In vitro protocol: 1. Donia T, Abouda M, Kelany M, Hessien M. β-Arrestin inhibition induces autophagy, apoptosis, G0/G1 cell cycle arrest in agonist-activated V2R receptor in breast cancer cells. Med Oncol. 2021 Mar 15;38(4):38. doi: 10.1007/s12032-021-01484-z. PMID: 33721131. 2. He Y, Liu H, Yin N, Yang Y, Wang C, Yu M, Liu H, Liang C, Wang J, Tu L, Zhang N, Wang L, He Y, Fukuda M, Wu Q, Sun Z, Tong Q, Xu Y. Barbadin Potentiates Long-Term Effects of Lorcaserin on POMC Neurons and Weight Loss. J Neurosci. 2021 Jun 30;41(26):5734-5746. doi: 10.1523/JNEUROSCI.3210-20.2021. Epub 2021 May 24. PMID: 34031163; PMCID: PMC8244968.
In vivo protocol: 1. He Y, Liu H, Yin N, Yang Y, Wang C, Yu M, Liu H, Liang C, Wang J, Tu L, Zhang N, Wang L, He Y, Fukuda M, Wu Q, Sun Z, Tong Q, Xu Y. Barbadin Potentiates Long-Term Effects of Lorcaserin on POMC Neurons and Weight Loss. J Neurosci. 2021 Jun 30;41(26):5734-5746. doi: 10.1523/JNEUROSCI.3210-20.2021. Epub 2021 May 24. PMID: 34031163; PMCID: PMC8244968.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Snyder J, Crooks VA, Johnston R, Cerón A, Labonte R. "That's enough patients for everyone!": Local stakeholders' views on attracting patients into Barbados and Guatemala's emerging medical tourism sectors. Global Health. 2016 Oct 7;12(1):60. PubMed PMID: 27717389; PubMed Central PMCID: PMC5055712.

2: Nelson OJ, Ward J, Forde AL, Ojeh N. Keloids: Current Therapies in Barbados. West Indian Med J. 2016 Mar 10. pii: wimj.2015.322. doi: 10.7727/wimj.2015.322. [Epub ahead of print] PubMed PMID: 27618292.

3: Bideau VS, Alleyne AT. Leu/Val SNP polymorphism of CYP1B1 and risk of uterine leiomyoma in a Black population. Tumour Biol. 2016 Mar;37(3):4035-40. doi: 10.1007/s13277-015-4239-8. Epub 2015 Oct 20. PubMed PMID: 26482777.

4: Fernandez MA, Kubow S, Gray-Donald K, Knight J, Gaskin PS. Drastic increases in overweight and obesity from 1981 to 2010 and related risk factors: results from the Barbados Children's Health and Nutrition Study. Public Health Nutr. 2015 Dec;18(17):3070-7. doi: 10.1017/S1368980015002190. Epub 2015 Jul 31. PubMed PMID: 26228380.

5: Christian T, Guell C. Knowledge and Attitudes of Cervical Cancer Screening Among Caribbean Women: A Qualitative Interview Study From Barbados. Women Health. 2015;55(5):566-79. doi: 10.1080/03630242.2015.1022816. Epub 2015 Apr 2. PubMed PMID: 25833319.

6: Gaskin PS, Hall RV, Chami P, St John MA, Gaskin DA, Molaodi OR, Harding S. Associations of blood pressure with body composition among Afro-Caribbean children in Barbados. PLoS One. 2015 Mar 27;10(3):e0121107. doi: 10.1371/journal.pone.0121107. eCollection 2015. PubMed PMID: 25815726; PubMed Central PMCID: PMC4376905.

7: Johnston R, Crooks VA, Snyder J, Whitmore R. "The Major Forces that Need to Back Medical Tourism Were … in Alignment": Championing Development of Barbados's Medical Tourism Sector. Int J Health Serv. 2015;45(2):334-52. doi: 10.1177/0020731414568512. PubMed PMID: 25813504.

8: Ojeh N, Rose A, Jackman S, Applewhaite M, Webster V. Feasibility of an electrostimulation system treatment for wound healing: a case series of patients with chronic ulcers in Barbados. Int Wound J. 2016 Dec;13(6):1180-1189. doi: 10.1111/iwj.12438. Epub 2015 Mar 10. PubMed PMID: 25756595.

9: Tookes JS. "The food represents": Barbadian foodways in the diaspora. Appetite. 2015 Jul;90:65-73. doi: 10.1016/j.appet.2015.02.011. Epub 2015 Feb 27. PubMed PMID: 25733378.

10: Johnston R, Adams K, Bishop L, Crooks VA, Snyder J. "Best care on home ground" versus "elitist healthcare": concerns and competing expectations for medical tourism development in Barbados. Int J Equity Health. 2015 Feb 3;14:15. doi: 10.1186/s12939-015-0147-1. PubMed PMID: 25643761; PubMed Central PMCID: PMC4320816.

11: Cropp CD, Robbins CM, Sheng X, Hennis AJ, Carpten JD, Waterman L, Worrell R, Schwantes-An TH, Trent JM, Haiman CA, Leske MC, Wu SY, Bailey-Wilson JE, Nemesure B. 8q24 risk alleles and prostate cancer in African-Barbadian men. Prostate. 2014 Dec;74(16):1579-88. doi: 10.1002/pros.22871. Epub 2014 Sep 22. PubMed PMID: 25252079; PubMed Central PMCID: PMC4322001.

12: Drescher O, Dewailly E, Krimholtz M, Rutchik J. 'Fishy' Make-up on the Hook for Mercury Exposure: A Case Series. West Indian Med J. 2013 Nov;62(8):770-2. doi: 10.7727/wimj.2013.034. PubMed PMID: 25014866.

13: Waber DP, Bryce CP, Fitzmaurice GM, Zichlin ML, McGaughy J, Girard JM, Galler JR. Neuropsychological outcomes at midlife following moderate to severe malnutrition in infancy. Neuropsychology. 2014 Jul;28(4):530-40. doi: 10.1037/neu0000058. Epub 2014 Mar 17. PubMed PMID: 24635710; PubMed Central PMCID: PMC4131534.

14: Quimby KR, Moe S, Sealy I, Nicholls C, Hambleton IR, Landis RC. Clinical findings associated with homozygous sickle cell disease in the Barbadian population--do we need a national SCD registry? BMC Res Notes. 2014 Feb 22;7:102. doi: 10.1186/1756-0500-7-102. PubMed PMID: 24558976; PubMed Central PMCID: PMC3936843.

15: Nemesure B, Wu SY, Hennis A, Leske MC. Distribution of Duffy Antigen Receptor for Chemokines (DARC) and Risk of Prostate Cancer in Barbados, West Indies. J Immigr Minor Health. 2015 Jun;17(3):679-83. doi: 10.1007/s10903-013-9970-x. PubMed PMID: 24399209; PubMed Central PMCID: PMC4087101.

16: Drakes N, Perks C, Kumar A, Quimby K, Clarke C, Patel R, Hambleton IR, Landis RC. Prevalence and risk factors for inter-generational sex: a cross-sectional cluster survey of Barbadian females aged 15-19. BMC Womens Health. 2013 Dec 27;13:53. doi: 10.1186/1472-6874-13-53. PubMed PMID: 24373740; PubMed Central PMCID: PMC3877959.

17: Quimby KR, Flower C, Hambleton IR, Landis RC, Hennis AJ. Comparison of the systemic lupus erythematosus activity questionnaire and the systemic lupus erythematosus disease activity index in a black barbadian population. Int J Rheumatol. 2013;2013:875369. doi: 10.1155/2013/875369. Epub 2013 Oct 24. PubMed PMID: 24282416; PubMed Central PMCID: PMC3824559.

18: Carrington S, Cohall DH, Gossell-Williams M, Lindo JF. The antimicrobial screening of a Barbadian medicinal plant with indications for use in the treatment of diabetic wound infections. West Indian Med J. 2012 Dec;61(9):861-4. PubMed PMID: 24020224.

19: Galler JR, Bryce CP, Zichlin ML, Waber DP, Exner N, Fitzmaurice GM, Costa PT. Malnutrition in the first year of life and personality at age 40. J Child Psychol Psychiatry. 2013 Aug;54(8):911-9. doi: 10.1111/jcpp.12066. Epub 2013 Mar 12. PubMed PMID: 23488644; PubMed Central PMCID: PMC3686988.

20: Nemesure B, Wu SY, Hennis A, Leske MC. Family history of prostate cancer in a black population. J Immigr Minor Health. 2013 Dec;15(6):1107-12. doi: 10.1007/s10903-012-9710-7. PubMed PMID: 22936456; PubMed Central PMCID: PMC3551989.